Back to Search Start Over

Standards for the care of people with cystic fibrosis; establishing and maintaining health.

Authors :
Southern KW
Addy C
Bell SC
Bevan A
Borawska U
Brown C
Burgel PR
Button B
Castellani C
Chansard A
Chilvers MA
Davies G
Davies JC
De Boeck K
Declercq D
Doumit M
Drevinek P
Fajac I
Gartner S
Georgiopoulos AM
Gursli S
Gramegna A
Hansen CM
Hug MJ
Lammertyn E
Landau EEC
Langley R
Mayer-Hamblett N
Middleton A
Middleton PG
Mielus M
Morrison L
Munck A
Plant B
Ploeger M
Bertrand DP
Pressler T
Quon BS
Radtke T
Saynor ZL
Shufer I
Smyth AR
Smith C
van Koningsbruggen-Rietschel S
Source :
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jan; Vol. 23 (1), pp. 12-28. Date of Electronic Publication: 2023 Dec 21.
Publication Year :
2024

Abstract

This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing and maintaining health. The guidance is produced using an evidence-based framework and with wide stakeholder engagement, including people from the CF community. Authors provided a narrative description of their topic and statements, which were more directive. These statements were reviewed by a Delphi exercise, achieving good levels of agreement from a wide group for all statements. This guidance reinforces the importance of a multi-disciplinary CF team, but also describes developing models of care including virtual consultations. The framework for health is reinforced, including the need for a physically active lifestyle and the strict avoidance of all recreational inhalations, including e-cigarettes. Progress with cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy is reviewed, including emerging adverse events and advice for dose reduction and interruption. This paper contains guidance that is pertinent to all people with CF regardless of age and eligibility for and access to modulator therapy.<br />Competing Interests: Declaration of competing interest KWS has no competing interests. See supplementary materials for full CoI statements for all authors.<br /> (Copyright © 2023. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-5010
Volume :
23
Issue :
1
Database :
MEDLINE
Journal :
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Publication Type :
Academic Journal
Accession number :
38129255
Full Text :
https://doi.org/10.1016/j.jcf.2023.12.002